What is Erythroblastosis fetalis?
Hemolytic disease of the newborn, also known as hemolytic disease of the fetus and newborn, HDN, HDFN, or erythroblastosis fetalis, is an alloimmune condition that develops in a fetus, when the IgG molecules (one of the five main types of antibodies) produced by the mother pass through the placenta. Among these antibodies are some which attack the red blood cells in the fetal circulation; the red blood cells are broken down and the fetus can develop reticulocytosis and anemia. This fetal disease ranges from mild to very severe, and fetal death from heart failure (hydrops fetalis) can occur. When the disease is moderate or severe, many erythroblasts are present in the fetal blood and so these forms of the disease can be called erythroblastosis fetalis (or erythroblastosis foetalis).
Questions and answers on "Erythroblastosis fetalis"
Health resources related to Erythroblastosis fetalis
- Diagnosis of erythroblastosis fetalis
- Symptoms of erythroblastosis fetalis
- Erythroblastosis fetalis causes
- Treatment and cure for erythroblastosis fetalis
- Drugs/medication for erythroblastosis fetalis
- Erythroblastosis fetalis bhcg
- Dental problems due to erythroblastosis fetalis
- How does rhogam decrease the risk of erythroblastosis fetalis